All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. - Wikidata - wikimedia - TriplyDB

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

http://www.wikidata.org/entity/Q35062106

about

Myeloid-derived suppressor cells: linking inflammation and cancer Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein The role of NKT cells in tumor immunity Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer Myeloid-Derived Suppressor Cells in Bacterial Infections Cancer-Associated Myeloid Regulatory Cells Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship Update on the challenges and recent advances in cancer immunotherapy Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer Monitoring of the Immune Dysfunction in Cancer Patients Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression Phenotype, development, and biological function of myeloid-derived suppressor cells Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs Myeloid-derived suppressor cells as regulators of the immune system Myeloid-derived cells are key targets of tumor immunotherapy Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics Coordinated regulation of myeloid cells by tumours The role of myeloid-derived suppressor cells in immune ontogeny Subsets of myeloid-derived suppressor cells in tumor-bearing mice High-dose dexamethasone or all-trans retinoic acid restores the balance of macrophage toward M2 in Immune thrombocytopenia.Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice Continuous retinoic acid induces the differentiation of mature regulatory monocytes but fails to induce regulatory dendritic cells Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity.Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.Very small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cells The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.AACR centennial series: the biology of cancer metastasis: historical perspective Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.Combination of physical activity, nutrition, or other metabolic factors and vaccine response Myeloid-derived suppressor cells in sepsis

P2860

Q24641811-94B91278-D479-41B1-B84A-A98E5A85B343 Q24641894-2826AE25-BDF7-458B-A19B-0548B801BB2B Q24648939-AD1D5841-1F7A-402B-BB57-15F05E5A5DC5 Q26741623-1961F4B9-9734-4AD3-9E94-819A3851B451 Q26749373-533A766F-5772-47A8-B3B7-00D76DBD4C42 Q26750382-E6BFE444-78B5-4751-83A2-F25DF82BAA55 Q26777205-EC465382-724D-49EB-9A78-C7EE4D23BEB0 Q26863418-8D6A502F-32B0-4E9E-9141-07195A27C1F2 Q26996829-08A8B96F-0B72-4C99-82D6-9A0210CC226A Q27000087-92618C8E-4AC2-44C7-9CE5-A45443D996C1 Q27014693-90B58B98-E654-4E6A-AB3E-F1404FA70854 Q28066486-3D8441BB-73A4-4F26-AC3E-2228D9CB01BF Q28072712-A9661E7C-7F55-4D86-B924-E1172056B588 Q28076161-21D796DA-F95E-4E26-8510-8BC89D7F2A95 Q28076760-6B102F67-5F71-4375-A48A-3637772C3FF2 Q28079046-B8652434-3235-472D-973F-0F3B036F51C2 Q28082461-321EF08F-1812-4B02-AF59-5D1BC0CDC993 Q28084627-2AC04442-7224-4818-AD8B-91D85F668803 Q28086980-53A624C5-D538-4C13-BCED-D1115A21D368 Q28131637-18151B8E-9025-4E08-B81E-D874186082A3 Q28388246-397473B7-92E0-4826-B95C-2665D8C7A058 Q28393614-12817268-9AEB-4A32-BF9C-1B6F3B402695 Q28395157-8AD9E4A0-B658-4FA3-8C6C-2DB2F09B461A Q28654584-B25E6999-90CB-4721-AA29-C2E46E8F666B Q29614297-8FBE24A9-EA4A-4F1C-A6C7-45C7697C4F76 Q33443380-51119594-B31B-40E9-B052-45263FC5D43C Q33474008-5A42E52B-3A3B-4261-8803-89CB0D6E70C3 Q33573652-E1A0D665-D229-4C42-83AF-603FA62935AD Q33592420-E0C54577-7610-4FC2-A011-75A93F20103D Q33598739-3AFDF672-1D83-448A-94EE-7666D8F8A9F3 Q33604925-B16CA7FD-125F-45AD-8869-B9021A4A4C7A Q33606107-51B8CD7F-DB61-41B6-944B-63C9561DE426 Q33606156-678D9DDF-0A2B-4B66-B09A-3477C464D17A Q33660069-F951F362-C51D-47A2-8E51-30D8D81D1166 Q33683443-6E05DBA6-0FEB-495E-B55A-69184AD41C78 Q33705930-E58666F1-7415-46F5-A2F7-F65E38E8B76F Q33707270-F913C4C7-DEDB-4389-95C4-458A079F190B Q33733198-CB04E57E-9EC4-48D6-98DC-9DEDA692B66B Q33751144-5D8BAE8B-D538-4EB4-9A48-676012FC5ECF Q33786718-67A4E74A-31B9-48B6-AE7B-420D7392794F

P2860

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

http://www.wikidata.org/entity/Q35062106

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

All-trans-retinoic acid improv ...... e response in cancer patients.

@ast

All-trans-retinoic acid improv ...... e response in cancer patients.

@en

type

label

All-trans-retinoic acid improv ...... e response in cancer patients.

@ast

All-trans-retinoic acid improv ...... e response in cancer patients.

@en

prefLabel

All-trans-retinoic acid improv ...... e response in cancer patients.

@ast

All-trans-retinoic acid improv ...... e response in cancer patients.

@en

P1433

Q35062106-F094354C-D73D-4BA2-8E9B-9B1CDAA40DF8

P1476

Q35062106-102C83B9-8DB9-4347-B520-8E38394E9F7E

P2093

Q35062106-223B3F9C-47C4-4D5D-88C8-3B2D12F2D8EF

Q35062106-2FC99870-B877-42BE-8607-2216232FFE30

Q35062106-70C95EFB-0D06-4371-9845-79F5F3375004

Q35062106-7780B6CC-015A-48DF-9CCC-11EE5868B1D4

Q35062106-92150408-7DC1-4715-BA56-441255ECF010

Q35062106-A41E614C-3D36-4B9A-8650-D9781CA8D3FC

Q35062106-B2707BC7-3879-4C77-B1F0-C108A1930778

Q35062106-C39ECD67-062A-47E2-9FC9-F9AC39281E61

Q35062106-E7191E61-9AA2-4091-BD94-534574CBD2F8

P2860

Q35062106-04108D1C-8FD4-41C2-B566-B2CF656AB68C

Q35062106-06784EB6-E5A3-41A3-9598-13F5D0F2903C

Q35062106-1FB543C9-4696-4130-A658-2D8ECCDAB091

Q35062106-22CC208F-AA3C-4416-8792-A6DF1D62D1D1

Q35062106-29C9A2CF-4E8A-48A5-8360-F58660DF4123

Q35062106-2B069A60-00E4-4392-B988-E5A496491E56

Q35062106-30CC4839-5F3B-4316-9804-37EB1BF74EA4

Q35062106-34F10B99-F170-4440-BB26-75B88BDE2221

Q35062106-3B49B2C3-5EFC-4BB3-B0C3-35E75B2718FC

Q35062106-4B503BE0-5436-46B6-93E7-F7B245909093

P304

Q35062106-35AB19F2-F8C3-45D2-BA53-8EAA428C5250

P31

Q35062106-7179479C-9FF9-4913-8033-E2D04A15F3DB

P356

Q35062106-539759B1-0085-4A04-9948-993466CDCB8A

P407

Q35062106-E6AF7128-533F-40A5-8A81-B371A90EA618

P433

Q35062106-A3FDACCB-CFD9-4FC1-928F-518B402784EF

P478

Q35062106-4097B06F-CFEA-4F65-9EA3-51CA680E89C4

P577

Q35062106-9D36DB42-7B27-46E1-9ADD-C9F4930EA700

P5875

Q35062106-A0C1CD70-9000-44CE-A62D-5BE198F87783

P698

Q35062106-C59AF331-856F-4A53-97C0-AD03492EFFCC

P932

Q35062106-5D17FCA5-6DFB-4866-B21B-390DEA6E6B4C

P356

0008-5472.CAN-06-1690

P1433

Cancer Research

P1476

All-trans-retinoic acid improv ...... e response in cancer patients.

@en

P2093

Anthony M Neuger

http://www.w3.org/2001/XMLSchema#string

Dmitry I Gabrilovich

http://www.w3.org/2001/XMLSchema#string

Ingo Fricke

http://www.w3.org/2001/XMLSchema#string

Mary Dunn

http://www.w3.org/2001/XMLSchema#string

Mayer Fishman

http://www.w3.org/2001/XMLSchema#string

Noweeda Mirza

http://www.w3.org/2001/XMLSchema#string

Richard M Lush

http://www.w3.org/2001/XMLSchema#string

Scott Antonia

http://www.w3.org/2001/XMLSchema#string

Timothy J Frost

http://www.w3.org/2001/XMLSchema#string

P2860

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results

Simultaneous determination of all-trans, 9-cis, 13-cis retinoic acid and retinol in rat prostate using liquid chromatography-mass spectrometry.

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.

Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.

Tumor-induced immune dysfunctions caused by myeloid suppressor cells.

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation.

Tumor escape from immune response: mechanisms and targets of activity.

Nuclear retinoid receptors and the transcription of retinoid-target genes.

Mechanisms and functional significance of tumour-induced dendritic-cell defects.

P304

9299-9307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-06-1690

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6811122

http://www.w3.org/2001/XMLSchema#string

P698

16982775

http://www.w3.org/2001/XMLSchema#string

P932

1586106

http://www.w3.org/2001/XMLSchema#string